| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |